The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of ginkgo biloba (steady state) on the
pharmacokinetics of a single dose of the UGT-substrate raltegravir. Furthermore the safety
profile of the combination is studied.